Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (87 total)
-
Creator: Menez, S., D. G. Moledina, H. Thiessen-Philbrook, F. P. Wilson, W. Obeid, M. Simonov, Y. Yamamoto, C. P. Corona-Villalobos, C. Chang, B. T. Garibaldi, W. Clarke, S. Farhadian, C. Dela Cruz, S. G. Coca, and C. R. Parikh.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-10-16
Description: Acute kidney injury (AKI) is common in patients with COVID-19 and associated with poor outcomes. Urinary biomarkers have been associated with adverse kidney outcomes in other settings and may provide additional prognostic information in patients with… -
Creator: Bar-On, Yinon M., Yair Goldberg, Micha Mandel, Omri Bodenheimer, Laurence Freedman, Nir Kalkstein, Barak Mizrahi, Sharon Alroy-Preis, Nachman Ash, Ron Milo, and Amit Huppert.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-10-07
Description: On July 30, 2021, the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons who were 60 years of age or older and who had received a second dose of vaccine at least 5… -
Creator: Barbaro, Ryan P., Graeme MacLaren, Philip S. Boonstra, Alain Combes, Cara Agerstrand, Gail Annich, Rodrigo Diaz, Eddy Fan, Katarzyna Hryniewicz, Roberto Lorusso, Matthew L. Paden, Christine M. Stead, Justyna Swol, Theodore J. Iwashyna, Arthur S.…
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-09-29
Description: Over the course of the COVID-19 pandemic, the care of patients with COVID-19 has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased. We aimed to examine patient selection, treatments, outcomes, and ECMO centre… -
Creator: Fintzi J, Bonnett T, Sweeney DA, Huprikar NA, Ganesan A, Frank MG, McLellan SLF, Dodd LE, Tebas P, Mehta AK.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-08-19
Description: The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) found that remdesivir therapy hastened recovery in patients hospitalized with COVID-19, but the pathway for this improvement was not explored. We investigated how the dynamics of clinical progression… -
![[14761645 - The American Journal of Tropical Medicine and Hygiene] Long-Term Assessment of the Effects of COVID-19 and Isolation Care on Survivor Disability and Anxiety.pdf](https://repository.netecweb.org/files/square_thumbnails/3c04d1951ed64666c198e9a4b76c8912.jpg "[14761645 - The American Journal of Tropical Medicine and Hygiene] Long-Term Assessment of the Effects of COVID-19 and Isolation Care on Survivor Disability and Anxiety.pdf")
Creator: Brett-Major DM, Cates DS, Lawler JV, Vokoun C, Hewlett AL, Johnson DW, Schnaubelt ES, Wadman MC, Kratochvil CJ, Broadhurst MJ.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-07-16
Description: We conducted an assessment of disability, anxiety, and other life impacts of COVID-19 and isolation care in a unique cohort of individuals. These included both community admissions to a university hospital as well as some of the earliest… -
Creator: the COVID-19 Genomics UK (COG-UK) consortium
Subject: Personnel Management
Item Type: Publication
Date Last Updated: 2021-08-27
Description: The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. It has since rapidly become the predominant lineage, owing to high transmissibility. It is suspected that the delta variant is associated with more severe disease… -
Creator: Barda, Noam, Noa Dagan, Yatir Ben-Shlomo, Eldad Kepten, Jacob Waxman, Reut Ohana, Miguel A. Hernán, Marc Lipsitch, Isaac Kohane, Doron Netzer, Ben Y. Reis, and Ran D. Balicer.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-08-25
Description: Preapproval trials showed that messenger RNA (mRNA)–based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety profile, yet these trials were subject to size and patient-mix limitations. An evaluation of the… -
Creator: Bourguignon, Alex, Donald M. Arnold, Theodore E. Warkentin, James W. Smith, Tania Pannu, Jeffrey M. Shrum, Zainab A. A. Al Maqrashi, Anjali Shroff, Marie-Claude Lessard, Normand Blais, John G. Kelton, and Ishac Nazy.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-08-19
Description: The use of high-dose intravenous immune globulin (IVIG) plus anticoagulation is recommended for the treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT), a rare side effect of adenoviral vector vaccines against coronavirus disease… -
Creator: Cirillo, Nicola, and Richard Doan.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-08-16
Description: In the past 100 days, more than 3 billion doses of SARS-CoV-2 vaccines have been administered globally. With 20 vaccines currently authorised in at least one country and 108 under clinical development as of July 20, 2021, there is ongoing public… -
Creator: CDC
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2021-08-18
Description: During this COCA Call, presenters will discuss the current data on COVID-19 vaccines in immunocompromised people; the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine…